PRMT2 and atherosclerosis: Remarkably, we found significant impairment of atherosclerosis regression under normoglycemic conditions in mice lacking PRMT2 (Prmt2−/−) in myeloid cells that mimic the decrease in regression of atherosclerosis in WT mice under diabetic conditions.